Moderna

As vaccinations continue across the U.S. and as children as young as 12 become eligible, what should you know about the COVID vaccines authorized for emergency use in the U.S.?

Moderna reported on Thursday that early data shows high effectiveness in its coronavirus vaccine trial in adolescents ages 12 to 17.

The company said a 50-microgram dose of its vaccine on already-vaccinated individuals generated a promising immune response against COVID-19 variants found in South Africa and Brazil.

Moderna released findings on Tuesday from its phase three trial which showed that its coronavirus vaccine is 90% effective at preventing infections and more than 95% effective against severe disease up to six months after the second dose.

With a third coronavirus vaccine now approved in the U.S., what is the difference between the vaccines and should you opt for one over the other?

With a third coronavirus vaccine nearing approval in the U.S., what is the difference between the vaccines and should you pick one over the other?

While planning when to receive the COVID-19 vaccine, remember Pfizer-BioNTech and Moderna shots require different lengths of time between doses.

While planning when to receive the COVID-19 vaccine, remember Pfizer and Moderna shots require different lengths of time between doses.

As new studies surrounding COVID vaccine efficacy and how long both the Pfizer and Moderna vaccines last continue to emerge, how can you know which is best for you?

The three vaccines currently available in the U.S. each offer some level of protection, but how long does the immunity last?

Here’s where vaccination eligibility stands in every state:

New research suggests the protection the Moderna vaccine gives against COVID-19 lasts for at least six months. The report published Tuesday in the New England Journal of Medicine echoes what Pfizer said last week about its vaccine, which works in a similar way.

The Moderna vaccine offers protection against COVID-19 for at least six months, according to a report in the New England Journal of Medicine.

More Johnson & Johnson doses are becoming available in both Chicago and Illinois, marking the only single-shot vaccine option for residents. So how effective is it and how does it compare to the Pfizer and Moderna vaccines?

The agency said late Thursday it approved new vials from Moderna that can contain up to 15 doses each, compared with the original vials designed to hold 10 doses. Additionally, regulators said providers can safely extract up to 11 doses from the original 10-dose vials. Those changes will be added to instructions for health care workers.

AstraZeneca released new data on its U.S. trial Monday as the company prepares to submit its findings to the U.S. Food and Drug Administration for emergency use authorization.

NIAID Director Dr. Anthony Fauci says the Food and Drug Administration will “place a great deal of scrutiny” on data from the AstraZeneca COVID-19 trial.

If herd immunity against the coronavirus is achieved, Lurie Children’s Hospital in Chicago could play a big role.

If herd immunity against the coronavirus is achieved, Lurie Children’s Hospital in Chicago could play a big role. NBC 5’s Chris Coffey reports.

As Chicago prepares to expand its vaccine eligibility, with hopes that additional supply becomes available, questions linger over the potential for additional vaccines.